Volume 13

Issue 3

Article 7

2005

Study of hypocholesterolemic and antiatherosclerotic properties
of Medicago sativa L. cultivated in Egypt

Follow this and additional works at: https://www.jfda-online.com/journal

Recommended Citation
Khaleel, A.E.; Gad, M.Z.; El-Maraghy, S.A.; Hifnawy, M.S.; and Abdel-Sattar, E. (2005) "Study of
hypocholesterolemic and antiatherosclerotic properties of Medicago sativa L. cultivated in Egypt," Journal
of Food and Drug Analysis: Vol. 13 : Iss. 3 , Article 7.
Available at: https://doi.org/10.38212/2224-6614.2519

This Original Article is brought to you for free and open access by Journal of Food and Drug Analysis. It has been
accepted for inclusion in Journal of Food and Drug Analysis by an authorized editor of Journal of Food and Drug
Analysis.

212
藥物食品分析

Journal of Food and Drug Analysis, Vol. 13, No. 3, 2005, Pages 212-218

第十三卷

第三期

Study of Hypocholesterolemic and Antiatherosclerotic
Properties of Medicago sativa L. Cultivated in Egypt
AMAL E. KHALEEL1, MOHAMED Z. GAD2, SHOHDA A. EL-MARAGHY3,
MOHAMED S. HIFNAWY1 AND ESSAM ABDEL-SATTAR4*
1.

Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
2.
3.

4.

Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt

Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt

Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, kingdom of Saudi Arabia
(Received: January 17, 2005; Accepted: May 20, 2005)

ABSTRACT
Alfalfa was reported to be hypocholesterolemic and antiatherosclerotic. Saponin glycosides were suggested to be responsible for
this activity by neutralizing cholesterol in the stomach, enabling it to be excreted from the body. This makes alfalfa superior to the
current anti-cholesterol medications which act by blocking cholesterol synthesizing apparatus. This study was undertaken in an attempt
to prepare an alfalfa extract with high saponin content and free or low content of other toxic constituents found in alfalfa (canavanine
and coumestrol), which causes serious side effects. A patent process was used to render alfalfa toxin free and to produce a drug present
in the international market. Our study is based on monitoring the Egyptian crop at two different localities for its saponin, canavanine
and coumestrol contents at different growth stages. The study showed that the tested extract of the chosen stage to be biologically
studied (hypocholesterolemic and antiatherosclerotic effects) on the basis of the highest saponin content was just before fruiting stage of
the locality A. This stage was free from both coumestrol and canavanine. The study proved that the Egyptian crop of alfalfa was found
to safely reduce natural cholesterol and to possess a strong antiatherosclerotic activity. This extract (I) produced the most significant
decrease in total cholesterol and LDL-cholesterol by 85.1 and 88%, respectively, of the corresponding levels in hypercholesterolemic
rabbits. This decrease is more significant than that produced by gemfibrozil (73 and 74%) upon concomitant administration with a cholesterol enriched diet using the same animal model at the tested dose level. Also, it was obvious that all alfalfa preparations produced
significant antioxidant properties. All alfalfa extracts possessed antiatherosclerotic activity as observed by the almost normalization of
the aortic sections upon concomitant use of alfalfa extracts with cholesterol-enriched diet.
Key words: alfalfa, saponins, canavanine, coumestrol, cholesterol, LDL, hypercholesterolemia, atherosclerosis

INTRODUCTION
Alfalfa, Medicago sativa L.(1,2) is a widely cultivated,
environmentally tolerant forage crop. Alfalfa is also known
as Lucerne, Buffalo Herb and Purple medic(2). The whole
plant material contains many important substances,
including steroidal saponins, sterols, coumarins, flavonoids,
isoflavones and coumestrol analogues, alkaloids, acids,
enzymes, vitamins, amino acids, sugars, proteins (25% by
weight), minerals, trace elements, and other nutrients(3).
Sprouts and seeds contain canavanine, a toxic amino acid
analogue of arginine derivative(4).
The alfalfa saponins of the aerial parts and roots have
been identified as mono-, bis-, or tridesmosides of medicagenic acid, hederagenin, zanhic acid and soysapogenol B(5).
Among them, medicagenic acid and hederagenin glycosides
have been recognized as the “biologically active” saponins.
The most often used methods of determining saponins are
based on the inhibition of the growth of Trichoderma virde
and plant seedlings or on the haemolytic activity(6).
* Author for correspondence. Tel: +996-2-6401000 ext. 22238;
Fax: +996-2-6951696; E-mail: abdelsattar@yahoo.com

Several reports suggested that saponins are responsible
for the reduction of cholesterol absorption and prevention
of atherosclerotic plaque formation in experimental
animals(7-9). Alfalfa meals prevented hypercholestrolemia,
triglyceridemia and atherogenesis in cholesterol fed
chicks(9), rabbits(10) and Cynomolgus monkeys(11).
Toxicity reported of alfalfa is due to its content of
alkaloid l-canavanine and the coumistan coumestrol(12).
Many commercial alfalfa products contain coumestrol (20190 ppm), which lead to pathological side effects.
Canavanine has been associated with systemic lupus-like
erythmatosus due to an alteration in red blood cells(12,13).
A preparation derived from a technically advanced patented
extraction process, which removed coumestrol and canavanine from alfalfa leaf and provided an extremely potent
form of saponins had been shown to reduce serum cholesterol levels without serious adverse effects(12).
Therefore, for the great medicinal value of this plant
and its potential in reducing hypercholesterolemia, the
Egyptian crop was studied with the aim of following up the
bioactive constituents at the different growth stages. One
of our main targets is to reach a proper extract that satisfies
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the criteria of being effective at proper concentrations and
has enough specificity for the indicated use.
Since saponin glycosides were shown to be responsible for the hypocholestrolemic effect(7-9), it was necessary
to estimate the percentage of saponins and to test the
presence or absence of canavanine and coumestrol in the
collected samples at the different growth stages.

MATERIALS AND METHODS
I. Plant Materials
The seeds bought from the Egyptian market were
germinated in Experimental Station of College of Pharmacy,
Cairo University (locality A). The seeds bought from
Fayoum Governorate were cultivated in the same place
(locality B). Different crops of the herb were collected
every 45 days from both localities starting from midNovember 2002 to mid-June 2003. Identification of the
plant material was carried out by Dr. H. A. Hosny, Professor
of Taxonomy, Faculty of Science, Cairo University.

coumestrol using TLC on silica gel plates against authentic
sample of coumestrol (limit of detection 1 µg/mL) using
chloroform/methanol (9:1, v/v, system 3) as developing
solvent. Coumestrol was visualized under UV 366 nm blue
fluorescent spot.
(III) HPLC Analysis of Coumestrol
HPLC analyses were performed on HP 1100 liquid
chromatograph with binary pump equipped with 1100 series
variable wavelength UV detector. Separation was
performed on RP-18 column 5 µm (250 × 4.5 mm I.D.).
Chromatographic runs were carried out with water/
methanol (2.1:1, v/v) at a flow rate of 1 mL/min and
monitored at 260 nm. Injection volume was 10 µL.
Standard coumestrol (0.8 mg/10 mL) was used.
The purified extract prepared above was filtered
through a membrane filter (45 µm) and 10 µL of the sample
was injected in the system adopting the conditions
mentioned above. Retention times and UV absorption
patterns of the tested samples were compared with the
authentic standard analyzed under the same condition (limit
of detection 5 ng/injection).

II. Preparation of Plant Extracts for Biological Evaluation
(IV) Determination of the Saponins Content
Samples for biological evaluation were prepared by
reflux of 5 kg of the plant material (combined of samples 4
and 5 of locality A) with 25 L of 30% ethanol (extract I) and
4 kg of the plant material with 20 L of water (extract II) for
1.5 hr twice. The combined extracts of each alcoholic and
water extracts were evaporated and kept in dissecator.

1. Haemolytic Method for Determination of Saponins
Samples from both localities at the different growth
stages were assayed using the method of El-Hossary G.
A.(14) The percentages of the haemolytic saponins calculated as white saponin of Merck are given in Table 1.

III Chemical Analysis
2. Colorimetric Methods for Determination of Saponins
(I) TLC Analysis for the Presence of Canavanine Alkaloid
Ten grams of each of the collected samples were
extracted by reflux twice with 100 mL of 30% methanol,
each time for 1.5 hr. The concentrated aqueous extract was
purified by extraction with chloroform followed by nbutanol saturated with water.
The concentrated n-butanol extract was tested for the
presence of canavanine on silica gel TLC precoated plates
and using n-butanol/acetic acid/water (80:20:20, v/v/v,
system 1) and chloroform/methanol/ammonia (40:40:20,
v/v/v, system 2) as solvent systems against authentic sample
of canavanine (limit of detection 5 µg/mL). The spots were
visualized by spraying with ninhydrin reagent.
(II) TLC Analysis of Coumestrol
Ten grams of each of the collected samples were
extracted by reflux twice with 100 mL of 90% methanol,
each time for 1.5 hr. The combined extracts were purified
by shaking with petroleum ether. The volume was adjusted
to 100 mL in a volumetric flask with methanol. The
methanolic extract was used to test for the presence of

A. Colorimetric Method Using Acetic Acid/Sulfuric Acid
Reagents
The procedure adopted in this assay was as described
by Honerlagen and Tretter(15).
B. Colorimetric Method Using Vanillin/Sulfuric Acid
Reagents
The procedure described by Hiai et al.(16) was followed.
Table 1. Percentage of saponins in the different growth stages of the
herb collected from the two localities (calculated as white saponin of
Merck)
Experimental station
Fayoum
Stage
(locality A)
(locality B)
Nov. 2002 (sample 1)
0.13
0.06
Jan. 2003 (sample 2)
0.12
0.07
Mar. 2003 (sample 3)
0.15
0.12
0.19a
May 2003 (sample 4)
0.19a
Jun. 2003 (sample 5)
0.20a
0. 11
a
The highest haemolytic saponin content calculated as white saponin
of Merck.
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IV. Biological Analysis
(I) Evaluation of Hypocholesterolemic Effect of the
Different Extracts
The protective effect of the alfalfa extracts against
hypercholesterolemia and development of atherosclerosis in
hyper-cholesterolemic rabbits were tested. Induction of
hypercholesterolemia was carried out by feeding rabbits [70
male New Zealand rabbits (Oryctolagus cuniculus),
weighing around 1.5-2 kg] 2% cholesterol-enriched diet for
28 days. Rabbits were classified into 7 groups. The first
group received cholesterol only for 28 days and served as a
control (hypercholesterolemic group). Four groups
received cholesterol-enriched diet containing the different
forms of alfalfa extracts [1 & 2% of extract I (30%
alcoholic) and 1 & 2% of extract II (aqueous) of combined
samples 4 and 5 of locality A, collected just before fruiting]
for a period of 28 days. A group received the cholesterolenriched diet for 28 days containing 40% ground seeds. An
additional group of rabbits was fed plain chow diet only
and served as a normal group.
In the end of the feeding experiments, food was
withheld for 16-18 hr and all animals were killed and
dissected. Blood and aorta were separated before following
investigations were performed:
1. Plasma lipid profile including total cholesterol
(TC)(17), triglycerides (TG)(18), HDL- & LDL-cholesterol (HDL-C & LDL-C)(19).
2. Histopathological examination of the aorta for
assessment of atherosclerosis.
3. Plasma malondialdehyde (MDA) level, as an index
of lipid peroxidation was determined colorimetrically based on the reaction of thiobarbituric acid with
the acid hydrolysed product of MDA(20).
(1) Histopathological Examination of the Rabbit Aorta
Staining of a paraffin section with Hematoxylin and
Eosin (Hx and E) was done according to the method of
Carleton (1967)(21).
The aorta was removed from the formol saline and a
block of hard paraffin with the tissue in its center was
prepared for sectioning. The paraffin (wax around the
organ) was dissolved by putting the slide in xylol solution
for 3 min, and then the xylol was replaced by alcohol by
putting the slide in absolute alcohol. The slide was
hydrated by putting it in descending grades of alcohol (in
100% alcohol then in 90% then in 70% alcohol and finally
distilled water) for 3 min in each step. The section was
stained in Hematoxylin for 7 min. This basic stain will stain
the nuclei and the basophilic structures of the cytoplasm
with a blue color. The slide was put in tap water for 5 min
to blue the section. Since the nuclei will appear darker after
tap water. The section was stained in Eosin for 1 min.
Eosin stains the acidophilic structures of the cytoplasm with
red color. The slide was then washed in distilled water for

3 min. Dehydration of the slide was done by putting it in
ascending grades of alcohol (for 1 min in 70% alcohol, then
for 3 min in 90% and for another 3 min in 100% alcohol).
The slide was put in xylol in order to clear it from alcohol
and to allow it to be miscible with Canada balsam. A drop
of Canada balsam was put on a clean cover and the slide
was removed from xylol with its face downwards and was
put quickly on the cover. The stained section was thus
ready for microscopical examination.
(2) Determination of Intimal Thickness
To avoid error due to pathological heterogeneity of
atherosclerosis, a total of ten specimens from the aorta of
one animal were subjected to the measurement of intimal
thickness (µm) by an image analyzer. This measurement
was done in Histology department, Faculty of Medicine,
Cairo University. The mean of the intimal thickness from
different sections represented the intimal thickness of the
animal. The average intimal thickness for 10 animals was
calculated for each group.
(II) Statistical Analysis
Data are presented as mean ± SEM. Statistical significance between groups was evaluated using Student’s t-test.

RESULTS
I. Chemical Analysis
It was found that all samples obtained from locality A
contain higher percentage of saponins than the corresponding samples collected from locality B. Sample 4 from both
localities and sample 5 from locality A, collected just
before fruiting (May-June) were the samples containing the
highest saponin content. Results are shown in Table 1.
TLC analysis revealed the presence of canavanine
alkaloid (as pink spot with ninhydrin reagent; Rf 0.12 in
system 1) only in the seeds bought from the market and
cultivated in locality A. Canavanine alkaloid was absent
from all other samples. TLC analyses of all herb samples
as well as seeds bought from market showed weak or very
weak bluish-violet fluorescent spot parallel to authentic
coumestrol (UV light, Rf 0.74, system 3), while the seed
sample from locality B showed absence of coumestrol.
However, HPLC analyses confirmed the absence of coumestrol in all samples from both sources.
II. Biological Analysis
(I) Effect of Cholesterol-enriched Diet
Feeding a 2% cholesterol-enriched diet to rabbits for
28 days resulted in a significant increase of plasma TC,
HDL-C and LDL-C levels reaching up to 1563, 260 and
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Table 2. Effect of alfalfa extracts on plasma lipid parameters and malondialdehyde levels
Plasma
Extract I (locality A)
Extract II (locality A)
Seeds 40%
Normal
Hypercholesterolemic
parametera
1%
2%
1%
2%
(locality B)
TC
88.1 ± 4.7
1376.0b ± 172.4
812.8c ± 73.0
204.5c ± 23.2
943.0 ± 137.8
374.9c ± 80.1
324.1c ± 39.1
b
c
c
c
c
70.4 ± 15.3
31.1 ± 4.8
22.7 ± 1.5
26.9 ± 3.0
18.8 ± 1.6
14.8c ± 1.5
HDL-C
27.1 ± 3.0
1280b ± 166.9
764.7c ± 74.3
153.3c ± 22.3
895.9 ± 135.9
337.8c ± 76.7
290.1c ± 39.8
LDL-C
34.5 ± 6.1
25.5 ± 3.1
18.1 ± 2.3
28.4 ± 14.0
20.3 ± 2.2
18.4 ± 3.4
19.2 ± 2.3
VLDL-C
26.6 ± 1.6
127.6 ± 15.5
93.3 ± 11.8
142.1 ± 14.0
101 ± 13.6
92.1 ± 17.0
96.0 ± 11.5
TG
132.9 ± 8.0
MDA
2.1 ± 0.14
5.8b ± 0.22
2.6c ± 0.17
3.0c ± 0.39
1.9c ± 0.29
2.3c ± 0.17
1.3c ± 0.17
a
TC: total cholesterol; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; VLDL-C: very low density
lipoprotein cholesterol; TG: triglycerides; MDA: malondialdehyde. Values are mean ± SEM (TC, HDL-C, LDL-C, VLDL-C& TG are in
mg/mL and MDA in nmol/mL).
b
Represents significant difference from normal at p < 0.05.
c
Represents significant difference from hypercholesterolemic control at p < 0.05.

(A)

Aortic intimal thickness in normal rabbit

50 µm

(B)

50 µm

Aortic intimal thickness in hypercholesterolemic rabbit

61.3

79.4

81.9

lntima

81.3
73.1

Medial vacuolations

Media

Figure 1. (A) A photomicrograph of a section in ascending aorta of a normal rabbit. Hx and E, 100×. (B) A photomicrograph of a section in
ascending aorta of a hypercholesterolemic rabbit. Hx and E, 100×.

3710% of normal values, respectively (Table 2). No change
in the levels of plasma VLDL-C and TG were noted. The
cholesterol-enriched diet also produced a significant
increase in plasma MDA level reaching to 276% of the
normal level (Table 2).
Histopathological examination of normal and hypercholesterolemic rabbits’ aorta (Figure 1A and B) revealed that in
normal rabbits, aorta wall has a uniform thickness with no
bulging in the lumen and the endothelial lining is intact without any interruption. On the other hand, hypercholesterolemia caused marked alterations in the aortic wall with
the appearance of multiple large atheromatous plaques.
Endothelial damage and massive degeneration with smooth
muscle proliferation were detected in the plaques. The average intimal thickness of aorta was multiplied almost 19 times
as compared to average normal aorta. Similar data were
demonstrated in rabbits fed a cholesterol-enriched diet(22).
(II) Effect of Alfalfa Extracts on the Cholesterol-enriched
Diet
The influence of 1 and 2% extracts I and II (locality
A) as well as the ground seeds from locality B on hyper-

cholesterolemia and atherogenicity was observed in hypercholesterolemic rabbits.
As shown in Table 2, all forms of alfalfa extracts
produced significant decrease in plasma total-, HDL- and
LDL-C levels, except 1% extract II. Upon comparison, 2%
of extract I produced the most significant decrease in TC
and LDL-C by 85.1 and 88%, respectively, of the corresponding levels in hypercholesterolemic rabbits; which is a
more significant decrease than that produced by gemfibrozil
(73 and 74%) upon administration concomitantly with a
cholesterol enriched diet using the same animal model(20).
Also, it was obvious that all alfalfa preparations produced
significant antioxidant properties (Table 2) by the significant reduction of the malondialdehyde (MDA) level.
It is worthy to mention that NO external signs of
toxicity appeared on the animals received cholesterolenriched diet containing the different forms of alfalfa
extracts, e.g. no weight loss, no diarrhea, and no abnormal
movements, no deaths, no outrageous violence, no noticeable sedation, no hair loss.
The beneficial effect of alfalfa preparations against
hypercholesterolemia and atherosclerosis was further
evaluated by histopathological examination of the aorta
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wall for the assessment of atherosclerosis in presence and
absence of the alfalfa intake. Remarkable inhibition of progression of intimal thickening by hypercholesterolemia was
noticed upon concomitant administration with all forms of
alfalfa extracts, as shown in Figures 2 and 3. The results
indicated normalization of the aortic walls with regard to
appearance and thickness.
The decrease in aortic thickness from average hypercholesterolemic aorta was 91%, 90%, 89%, 89%, 91% for
the groups 1% extract I, 2% extract I, 1% extract II, 2%

extract II (locality A), and ground seeds (locality B),
respectively.

(A)

Aortic intimal thickness in 1% alcoholic extract

(B)

Aortic intimal thickness in 2% alcholic extract

(C)

Aortic intimal thickness in 1% aqueous extract

(D)

Aortic intimal thickness in 2% aqueous extract

(E)

Aortic intimal thickness in seed group

50 µm

50 µm

DISCUSSION
I. Chemical Analysis
Trials for determining the saponin content using colorimetric methods (acetic acid/sulfuric acid(15) and vanillin/
50 µm

50 µm

50 µm

Figure 2. Photomicrographs of sections in ascending aorta of alfalfatreated hypercholesterolemic rabbits. Hx and E, 100×. (A) 1%
alcoholic extract; (B) 2% alcoholic extract; (C) 1% aqueous extract;
(D) 2% aqueous extract; (E) seed.

217
Journal of Food and Drug Analysis, Vol. 13, No. 3, 2005

180

a

Intimal thickness (µm)

160
140

Normal

120

Hyperchol.
1% Ext I

100

2% Ext I
80

1% Ext II

60

2% Ext II
Seeds

40
20

b

b

b

b

b

0

Figure 3. Intimal thickness of aorta in normal, hypercholesterolemic,
1% extract I, 2% extract I, 1% extract II, 2% extract II, and seeds
groups. Values are means ± SEM. Each mean represents the average
reading of 10 sections for each aorta for 7 animals (i.e. each reading
is an average of 70 values). aSignificant difference from normal at p
< 0.05. bSignificant difference from hypercholesterolemic control at
p < 0.05

(16)

sulfuric acid reagents ) were found to be unsuccessful.
Therefore, the saponin content was estimated in the
different growth stages of two crops cultivated in locality A
and locality B using the haemolytic index method which is
one of the methods used for determining the biologically
active compounds(6). For safety, the presence or absence of
canavanine and coumestrol in all the collected samples of
the herb as well as their respective seed samples were
tested. All the tested growth stages of the herb were free
from both substances.
II. Biological Analysis
The remarkable plasma TC, LDL-C and HDL-C
elevation observed in our study upon cholesterol feeding is
in agreement with several studies. It was obvious that the
dramatic increase in plasma total cholesterol originated
from the remarkable increase in LDL-C rather than HDL-C.
It was also noticeable that despite the dramatic increase in
plasma TC upon cholesterol feeding, plasma TG was not
elevated at the end of the 28-day study. Similar results
were reported by Wojcicki et al.(23) and Sugano et al.(24).
A reasonable explanation is the assumption that elevated
post-heparin lipolytic activity previously observed in hypercholesterolemic group(20) is sufficient to abolish the hypertriglyceridemia anticipated with cholesterol feeding.
Another significant increase observed with cholesterol
feeding is the two-fold elevation in the plasma MDA level.
This result indicates that hypercholesterolemia could
enhance the process of lipid peroxidation.
All forms of alfalfa extracts produced significant
decrease in plasma total-, HDL- and LDL-C levels, except
1% extract II, according to the following order: 2% extract
I > seeds > 2% extract II > 1% extract I > 1% extract II.
Also, ratiowise 2% extract I showed the best HDL-C/LDLC ratio (0.148) as compared to other extracts which had
ratios ranging between 0.039 to 0.056, which are compara-

ble to hypercholesterolemic group (0.055). However, 2%
of extract I did not show the lowest level of MDA, despite
its significance.
The absence of external signs of toxicity on the
animals received cholesterol-enriched diet containing the
different forms of alfalfa extracts confirmed the obtained
results of TLC and HPLC which showed the absence of
both of coumestrol and canavanine from the tested extracts.
Histopathological examination of aorta of alfalfa-fed
rabbits revealed almost normalization of the aortic wall
sections with regard to appearance (Figure 2) and intimal
thickness (Figure 3). There was no difference between the
results of the treated groups, suggesting that the antiatherosclerotic activity of the extracts might be noticeable in even
lower concentration of the active constituents.

CONCLUSIONS
Several studies(9-12, 25) have reported the hypocholesterolemic and antiatherosclerotic activities of alfalfa
extracts. This study showed that:
1. The high level of serum cholesterol and MDA
seems to contribute to the histopathological changes
developed in the aortic wall as evidenced by the comparison of alfalfa-treated animals with the hypercholesterolemic
and normal groups.
2. Alfalfa extracts exhibited highly significant antioxidant activity.
3. 2% extract I of the Egyptian crop produced the most
significant decrease in TC and LDL-C.
4. All alfalfa extracts possessed antiatherosclerotic
activity as observed by the almost normalization of the
aortic sections upon concomitant use of alfalfa extracts with
cholesterol-enriched diet.
5. The result of 30% alcoholic extract was more
effective than both ground seeds and the aqueous extract of
the herb. The activity cannot be attributed only to the
saponin content, but to the effect of other components in
addition to saponins which may be present in this extract
and absent in the aqueous extract.
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